Skip to main content
. 2016 Jul 10;31(3):340–350. doi: 10.1177/0269215516640320

Table 2.

Outcome measures (median, minimum, maximum) for intervention and control at each time point. *Mann Whitney indicated significantly larger improvement in the intervention group than the control at P<0.05, ** significant at P<0.01. For full explanation see text.

Outcome measures Baseline
Midpoint
Effect size (r) of baseline/ midpoint comparison Final
Effect size (r) of baseline/ final comparison
Intervention Control Intervention Control Intervention Control
Wolf MFT (secs) Patients completing final outcome measures 2.00
(1.49, 16.15)
N = 9
2.72
(1.19, 8.84)
N = 9
2.22
(1.00, 8.03)
N = 9
2.28
(1.18, 6.22)
N = 9
2.47
(1.06, 6.58)
N = 9
2.19
(1.43, 5.62)
N = 9
0.40
N = 18
Patients who did not complete final outcome measures 2.21
(1.49, 16.15)
N = 12
2.60
(1.19, 8.84)
N = 10
2.44
(1.00, 10.25)
N = 12
2.17
(1.18, 6.22)
N = 10
0.17
N = 22
Wolf Grip Patients completing final outcome measures 14.55
(6.33, 35.10)
N = 8
12.77
(2.20, 47.27)
N = 9
20.17
(5.83, 37.5)
N = 9
12.23
(3.97, 34.70)
N = 9
12.80
(2.30, 37.47)
N = 9
12.53
(5.03, 29.40)
N = 9
1.37
N = 18
Patients who did not complete final outcome measures 12.93
(1.93, 35.10)
N = 11
14.25
(2.20, 47.27)
N = 10
15.50
(2.23, 37.50)
N = 12
13.50
(3.97, 34.70)
N = 10
0.51*
N = 21
NHPT (secs) Affected arm Patients completing final outcome measures 45.17
(40.16, 292.52)
N = 8
45.66
(31.50, 136.41)
N = 7
55.45
(31.28, 270.18)
N = 8)
43.81
(31.27, 109.60)
N = 9
53.34
(36.93, 311.92)
N = 8
37.39
(27.79, 120.85)
N = 7
1.34
N = 15
Patients who did not complete final outcome measures 53.06
(26.68, 292.52)
N = 11
46.44
(31.50, 136.41)
N = 8
53.65
(25.45, 270.18)
N = 11
43.12
(31.27, 109.60)
N = 8
0.04
N = 19
MAL amount of use Patients completing final outcome measures 66.00
(21.00, 113.00)
N = 9
69.00
(24.00, 150.00)
N = 9
74.00
(34.00, 130.00)
N = 9
83.00
(38.00, 145.00))
N = 9
76.00
(22.00, 135.00)
N = 9
56.00
(18.00, 125.00)
N = 9
2.26*
N = 18
Patients who did not complete final outcome measures 69.00
(21.00, 140.00)
N = 12
69.50
(24.00, 150.00)
N = 10
81.50
(34.00, 149.00)
N = 12
81.00
(38.00, 145.00)
N = 10
−0.01
N = 22
MAL quality of movement Patients completing final outcome measures 54.00
(10.00, 86.00)
N = 9
53.00
(16.00, 133.00)
N = 9
61.00
(32.00, 117.00)
N = 9
67.00
(27.00, 132.00)
N = 9
74.00
(25.00, 125.00)
N = 9
51.00
(9.00, 122.00)
N = 9
1.68
N = 18
Patients who did not complete final outcome measures 60.00
(10.00, 130.00)
N = 12
56.00
(16.00, 133.00)
N = 10
69.00
(32.00, 145.00)
N = 12
65.00
(27.00, 132.00)
N = 10
0.20
N = 22
MAL activities attempted Patients completing final outcome measures 17.00
(8.00, 23.00)
N = 9
16.00
(7.00, 30.00)
N = 9
18.00
(13, 26)
N = 9
19.00
(10.00, 29.00)
N =9
20.00
(9.00, 27.00)
N = 9
17.00
(6.00, 29.00)
N = 9
2.50**
N = 18
Patients who did not complete final outcome measures 18.00
(8.00, 28.00)
N = 12
16.00
(7.00, 30.00)
N = 10
20.00
(13.00, 30.00)
N = 12
19.00
(10.00, 29.00)
N = 10
−0.04
N = 22
NEADL Patients completing final outcome measures 38.00
(22.00, 59.00)
N = 9
39.00
(15.00, 63.00)
N = 9
41.00
(20.00, 57.00)
N = 9
50
(13.00, 62.00)
N = 9
39.00
(28.00, 57.00)
N = 9
46.00
(11.00, 63.00)
N = 9
1.06
N = 18
Patients who did not complete final outcome measures 39.00 (12.00, 63.00)
N = 12
41.00 (15.00, 63.00)
N = 10
42.00 (13.00, 63.00)
N = 12
48.50
(13.00, 62.00)
N = 10
0.09
N = 22

Wolf MFT: Wolf Motor Function Test, NHPT: Nine Hole Peg Test, MAL: Motor Activity Log, NEADL: Nottingham Extended Activities of Daily Living.